Skip to main content
. Author manuscript; available in PMC: 2009 Sep 28.
Published in final edited form as: Cancer Chemother Pharmacol. 2008 May 29;63(4):615–625. doi: 10.1007/s00280-008-0774-y

Fig. 3.

Fig. 3

HPLC chromatograms of 10058-F4 and metabolites in plasma. a Plasma obtained from a control animal with internal standard (fenretinide, 4-HPR) added, b the chromatogram of 10058-F4 added to plasma as a quality control assay standard, c the chromatogram of 10058-F4 and metabolites in plasma obtained 30 min after treating a mouse with 20 mg/kg of 10058-F4 i.v.